Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Annual Report to the Nation: Declines in lung cancer, melanoma death rates drive overall cancer mortality drop

Annual Report to the Nation: Declines in lung cancer, melanoma death rates drive overall cancer mortality drop

July 09, 2021
Vol.47 No.27
By Alexandria Carolan
Single digits: Black, Hispanic scientists strikingly underrepresented at NCI among senior workforce and grantees
FreeHealth Equity

Single digits: Black, Hispanic scientists strikingly underrepresented at NCI among senior workforce and grantees

July 02, 2021
Vol.47 No.26
By Matthew Bin Han Ong
Racial, ethnic minorities are systemically underrepresented in leadership teams across NCI cancer centers
Conversation with The Cancer LetterFreeHealth Equity

Racial, ethnic minorities are systemically underrepresented in leadership teams across NCI cancer centers

June 25, 2021
Vol.47 No.25
By Matthew Bin Han Ong
Will cancer centers remain committed to improving equity in the long term?
FreeHealth Equity

Will cancer centers remain committed to improving equity in the long term?
Cancer center leaders discuss their hiring and diversity pipeline efforts

June 25, 2021
Vol.47 No.25
By Matthew Bin Han Ong
Biden’s budget request for NCI would set back Sharpless’s goal of raising R01 paylines to 15%
NCI

Biden’s budget request for NCI would set back Sharpless’s goal of raising R01 paylines to 15%

June 18, 2021
Vol.47 No.24
By Alexandria Carolan
ARPA-H would launch 1,000 drugs, Eric Lander promises NIH advisors
News Analysis

ARPA-H would launch 1,000 drugs, Eric Lander promises NIH advisors

June 18, 2021
Vol.47 No.24
By Matthew Bin Han Ong
Senate leaders show bipartisan support for Biden’s FY22 request to increase NIH budget by $9B, including $6.5B for ARPA-H
FreeWhite House

Senate leaders show bipartisan support for Biden’s FY22 request to increase NIH budget by $9B, including $6.5B for ARPA-H

June 04, 2021
Vol.47 No.22
By Matthew Bin Han Ong
Here’s something for the Bidens and ARPA-H to do: Build a national, federated ecosystem for digital health, MITRE proposes
Conversation with The Cancer LetterReal-world Evidence

Here’s something for the Bidens and ARPA-H to do: Build a national, federated ecosystem for digital health, MITRE proposes

May 21, 2021
Vol.47 No.20
By Matthew Bin Han Ong
David Tuveson: NCI needs more funding to increase success rate of RPGs
Capitol Hill

David Tuveson: NCI needs more funding to increase success rate of RPGs

May 21, 2021
Vol.47 No.20
By Alexandria Carolan
Biden urges Congress to fund ARPA-H as OSTP nominee Eric Lander defines agency’s mission

Biden urges Congress to fund ARPA-H as OSTP nominee Eric Lander defines agency’s mission

April 30, 2021
Vol.47 No.17
By Matthew Bin Han Ong

Posts navigation

Previous1…394041Next

Trending Stories

  • Is it time to re-assess the practice and practicality of screening colonoscopy?
    Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives
  • NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprises
    New NOFO aims to shrink applications by 40%
  • California’s Prop 38 is an historic approach to funding medical research, immunology
    The $8.4B bond makes a long-term investment in a field with life-saving power
  • Rachna Shroff, accomplished GI oncologist and “tireless mentor,” dies at 47
    Her endowed award will live on
  • Facing stage 4 cholangiocarcinoma, Keaton Herzer moved mountains to take off-label therapy, get a transplant
    Two years later, he has no evidence of disease
  • From “default dead” to living the future of cancer care
    As founding CEO of GitLab, I went “founder mode” on my osteosarcoma

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account